Vikas Lifecare share news, announcements and annual reports
NSE: VIKASLIFEBSE: 542655Commercial Services & SuppliesSmall Cap
Vikas Lifecare Limited · Formerly Vikas Multicorp · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2019
Last close ₹1.11down ₹0.01 (0.89%)BSE ₹1.11
Share price at the NSE close on 30 Oct 2026. Previous close ₹1.12.
30 Oct: open ₹1.12, high ₹1.13, low ₹1.10
52-week range of traded prices to 30 Oct 2026
₹1.05Low, 30 Mar 2026₹2.10High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹206 Cr2,160th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 18,86,86851.1% delivered
Vikas Lifecare disputes and clarifications
31 filed, newest first.
Aug 2026
Jul 2026
31 Jul · Legal
Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.17 Jul · Legal
Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Jun 2026
25 Jun · Legal
Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Impact of Audit Qualifications in case of modified opinion(s) The response of the Company is awaited.
Aug 2024
Jun 2024
23 Jun · Legal
Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Oct 2022
14 Oct · Legal
Exchange has sought clarification from Vikas Lifecare Limited with respect to announcement dated 14-Oct-2022 informing about General Updates.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief). 2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm's length"; 3. Indicative time period for completion of the acquisition; The response of the company is awaited.12 Oct · Legal
Exchange has sought clarification from Vikas Lifecare Limited with respect to announcement dated 10-Oct-2022 informing about General updates.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Brief details of any governmental or regulatory approvals required for the acquisition; 2. Nature of consideration - whether cash consideration or share swap and details of the same; The response of the company is awaited.
Feb 2022
18 Feb · Legal
Exchange has sought clarification from Vikas Lifecare Limited with respect to announcement dated 16-Feb-2022, regarding appointment of Mr. (Dr.) Sundeep Kumar Dhawan as Managing Director of the Company and resignation of Ms. Preeti Gupta as Independent Director of the Company at its board meeting held on February 15, 2022.On basis of above the Company is required to clarify following -1. Confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018;2. The Letter of resignation of the independent director mentioning the detailed reasons for the resignation.The response of the Company is awaited.
Sep 2021
27 Sep · Legal
Exchange has sought clarification from Vikas Lifecare Limited with respect to announcement dated 24-Sep-2021, regarding board meeting held on September 24, 2021. On basis of above the Company is required to clarify following - 1. Confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018 (in case of appointment of directors); 2. Detailed Reasons for Resignation (resignation of independent director). The response of the Company is awaited.
Aug 2021
27 Aug · Legal
Exchange has sought clarification from Vikas Lifecare Limited with respect to announcement dated 25-Aug-2021, regarding Outcome of Board meeting held on August 25, 2021. On basis of above the Company is required to clarify following: 1. Amendments to Memorandum and/or Articles of association of listed entity, in brief.2. Confirmation from the resigning director that there are no other material reasons other than provided3. Detailed Reasons for Resignation of director4. Details as per Annexure A of SEBI Circular CIR/CFD/CMD1/114/2019 dated October 18, 2019 w.r.t Resignation of statutory auditors from listed entitiesThe response of the Company is awaited.20 Aug · Legal
Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Jun-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Jul 2021
20 Jul · Legal
Exchange has sought clarification from Vikas Lifecare Limited with respect to announcement dated 19-Jul-2021, regarding proposal to acquire M/s Hydrolina Biotech Private Limited. On basis of above the Company is required to clarify following: 1. Name of the target entity, details in brief such as size, turnover etc;2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm's length";3. Cost of acquisition or the price at which the shares are acquired;4. Nature of consideration - whether cash consideration or share swap and details of the same;5. Percentage of shareholding / control acquired and / or number of shares acquired;The response of the Company is awaited.15 Jul · Legal
Exchange has sought clarification from Vikas Lifecare Limited with respect to announcement dated 14-Jul-2021, regarding 'Vikas Lifecare acquired 22.04% stake in Advik Laboratories Ltd'. On basis of above the Company is required to clarify following: 1. Name of the target entity, details in brief such as size, turnover etc;2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm's length";3. Cost of acquisition or the price at which the shares are acquired;The response of the Company is awaited.12 Jul · Legal
Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Financial results submitted is not as per format prescribed by SEBI -3. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
Jun 2021
29 Jun · Legal
Exchange has sought clarification from Vikas Lifecare Limited with respect to announcement dated 25-Jun-2021, regarding acquisition of a start-up Green life Agritech. On basis of above the Company is required to clarify following: 1. Name of the target entity, details in brief such as size, turnover etc;2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm's length";3. Brief details of any governmental or regulatory approvals required for the acquisition;4. Indicative time period for completion of the acquisition;5. Cost of acquisition or the price at which the shares are acquired;6. Nature of consideration - whether cash consideration or share swap and details of the same;7. Percentage of shareholding / control acquired and / or number of shares acquired;8. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief). The response of the Company is awaited.
Nov 2020
Oct 2020
27 Oct · Legal
Exchange has sought clarification from Vikas Multicorp Limited for the quarter ended 30-Sep-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone Balance sheet statement not submitted -2. Statement of Cash Flow not submitted -3. Segment details not submitted -4. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
Aug 2020
27 Aug · Legal
The exchange asked on 26 Aug 2020
Jul 2020
13 Jul · Legal
Exchange has sought clarification from Vikas Multicorp Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. The response of the Company is awaited.
Feb 2020
14 Feb · Legal
Exchange has sought clarification from Vikas Multicorp Limited for the quarter ended 31-Dec-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. The response of the Company is awaited.
Nov 2019
Jul 2019
26 Jul · Legal
Exchange has sought clarification from Vikas Multicorp Limited with respect to announcement dated 19-Jul-2019, regarding Credit Rating. On basis of above the Company is required to clarify following: 1. In case of downward rating, the disclosure may include reasons published by rating agency for such downward rating. 2. Promptly notify the Exchange, but not later than 24 hoursThe response of the Company is awaited.
May 2019
15 May · Legal
The exchange asked on 13 May 2019